Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quintiles Dedicates New Facility in Kansas | Contract Pharma

What are you searching for?

Sign in
Breaking News

Quintiles Dedicates New Facility in Kansas

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dennis Gillings, CBE, chairman and chief executive officer of Quintiles Transnational Corp., dedicated a new facility in Overland Park, KS, with Secretary David Kerr of the Kansas Department of Commerce.

The 236,000-sq.-ft. building will house Quintiles’ regional Clinical Development Services (CDS) and clinical pharmacology units previously located in Kansas City, MO, as well as the Phase I clinical research unit that had been in Lenexa, KS. The new Phase I unit has a 150-bed capacity—three times the size of the Lenexa unit—and can accommodate an additional 200 employees.

“The new facility gives the Overland Park office the room it needs to expand its activities in support of regional and global clinical research,” said Mr. Gillings. “Ultimately, however, this building is about even more than the creation of jobs in Overland Park and the growth of Quintiles, it’s about improving healthcare for people in Kansas, across the U.S. and around the world.”

Quintiles employs approximately 750 full-time workers in the Kansas City area in CDS, Clinical Pharmacology and Phase I.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters